Nuestra política de devoluciones para productos defectuosos es la siguiente:
TITULO 21--ALIMENTOS Y MEDICAMENTOS CAPITULO I--ADMINISTRACIÓN DE ALIMENTOS Y MEDICAMENTOS DEPARTAMENTO DE SALUD Y SERVICIOS HUMANOS
SUBCAPÍTULO C - DROGAS: GENERAL
PARTE 211 - BUENAS PRÁCTICAS DE FABRICACIÓN ACTUAL PARA PRODUCTOS FARMACÉUTICOS TERMINADOS:
Subparte K - Productos farmacéuticos devueltos y recuperados
Segundo. 211.204 Medicamentos devueltos
*Costos de Envío: Los costos de envío para la devolución de productos defectuosos serán cubiertos por nuestra empresa.
ENGLISH:
Our return policy for defective products is as follows:
TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER C - DRUGS: GENERAL PART 211 - CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS:
Subpart K - Returned and Salvaged Drug Products
Sec. 211.204 Returned drug products
Returned drug products shall be identified as such and held. If the conditions under which returned drug products have been held, stored, or shipped before or during their return, or if the condition of the drug product, its container, carton, or labeling, as a result of storage or shipping, casts doubt on the safety, identity, strength, quality, or purity of the drug product, the returned drug product shall be destroyed unless examination, testing, or other investigations prove that the drug product meets appropriate standards of safety, identity, strength, quality, or purity. A drug product may be reprocessed provided the subsequent drug product meets appropriate standards, specifications, and characteristics. Records of returned drug products shall be maintained and shall include the name and label potency of the drug product dosage form, lot number (or control number or batch number), reason for the return, quantity returned, date of disposition, and the ultimate disposition of the returned drug product. If the reason for a drug product return implicates associated batches, an appropriate investigation shall be conducted in accordance with the requirements of § 211.192. Procedures for the holding, testing, and reprocessing of returned drug products shall be in writing and shall be followed.
Return Period: Defective products may be returned within 30 days of receiving the order.
Product Condition: The product must be in its original packaging and unused. Returns of opened or used products will be evaluated on a case-by-case basis.
Documentation: Proof of purchase and a detailed description of the observed defect must be provided.
Shipping Costs: The shipping costs for returning defective products will be covered by our company.